title: Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case?
abstract: Tumor necrosis factor-alpha (TNF-α) antagonists have advanced treatment of psoriasis and other chronic inflammatory diseases but are not free of adverse effects. Pyogenic granuloma is yet described in literature as a dermatological side effect of multiple drugs such as retinoids, antiretroviral, and antineoplastic drugs but, to the best of our knowledge, it has never been reported among the adverse skin reactions following anti-TNF-α therapy. We report on a 20-year-old Caucasian man with psoriatic arthritis who developed multiple eruptive periungual and subungual pyogenic granulomas following treatment with TNF-α antagonist etanercept.
authors.affiliation: Department of Dermatology, University of Naples Federico II, Naples, Italy.
authors.forename: Cataldo
authors.initials: C
authors.lastname: Patruno
authors.forename: Nicola
authors.initials: N
authors.lastname: Balato
authors.forename: Teresa
authors.initials: T
authors.lastname: Cirillo
authors.forename: Maddalena
authors.initials: M
authors.lastname: Napolitano
authors.forename: Fabio
authors.initials: F
authors.lastname: Ayala
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D000068800:Etanercept; D017789:Granuloma, Pyogenic / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D007279:Injections, Subcutaneous; D008297:Male; D009260:Nail Diseases / Q000139:chemically induced* / Q000175:diagnosis; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept
keywords: etanercept; psoriasis; pyogenic granuloma